Zydus to begin phase-II (a) clinical trial of oral inflammasome inhibitor in patients with… EP News Bureau Dec 14, 2021 Cryopyrin-Associated Periodic Syndrome (CAPS) is a rare life-long auto-inflammatory condition, caused by NLRP3 activating…
